Ying L

No ORCID on file · 5 papers in corpus
other 2026
Computational biology and chemistry ·doi:10.1016/j.compbiolchem.2026.109118

AIMS: This study aims to develop and validate a Multi-Dimensional Computational Screening (MDCS) strategy to identify bioactive components by jointly considering target affinity, exposure potential, and safety, using Liangdi decoction (LDD)…

observational 2026
Scientific reports ·doi:10.1038/s41598-026-56780-3

This study utilized the Surveillance, Epidemiology, and End Results (SEER) database to identify clinicopathological prognostic factors and develop a prognostic nomogram for predicting 1-, 3-, and 5-year overall survival (OS) in patients wit…

lab-animal 2025
Frontiers in oncology ·doi:10.3389/fonc.2025.1537528

PURPOSE: The present study investigated the expression and role of miR-183 in the proliferation, invasion, migration, and apoptosis of endometrial stromal cells in endometriosis patients and the potential involvement of targeting Ezrin. ME…

nonrandomized-trial 2023
Frontiers in medicine ·doi:10.3389/fmed.2023.1269733

OBJECTIVE: To evaluate the efficacy of hysteroscopic hysteroplasty in the treatment of uterine malformation complicated by primary reproductive disorders. METHODS: Women with unexplained primary infertility, repeated in vitro fertilization…

other 2016
Oncotarget ·doi:10.18632/oncotarget.13294

Our previous study found copy number variation of chromosome fragment 5p13.1-13.3 might involve in the progression of ovarian cancer. In the current study, the alteration was validated and complement component 7 (C7), located on 5p13.1, was…